Michael Tocco

机构：Nelson Marlborough Institute of Technology, Universitas Sutomo, Sumitomo Dainippon Pharma (United States) · ORCID：0000-0003-1474-6666

发表论文 124 篇 · 总被引 617 次 · h-index 11

代表论文

Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia (2022 · European Psychiatry · 被引 15)
Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression (2021 · Journal of Child and Adolescent Psychopharmacology · 被引 11)
Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression (2022 · Current Neuropharmacology · 被引 9)
The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression (2023 · The Journal of Clinical Psychiatry · 被引 8)
The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis (2022 · Journal of Medical Economics · 被引 6)
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis (2022 · Schizophrenia Research · 被引 6)